UnitedHealth Falls About 6% as CMS Anti-Fraud Rule Hits Insurers and the Dow
UnitedHealth and Humana fell about 6% on Nov. 18 after CMS's CRUSH proposal to extrapolate Medicare Advantage audits, a rule CMS puts at about $9B a year.

UnitedHealth and Humana each fell about 6% during the Nov. 18 session after CMS proposed an anti-fraud rule that would widen audits of Medicare Advantage plans. The drop pulled the Dow down about 0.9% to roughly 50,300 midday, according to Yahoo Finance, so it matters well beyond health care.
What happened
CMS released the proposal, called CRUSH (Comprehensive Regulations to Uncover Suspicious Healthcare, CMS-6098-P), on Nov. 16. Its Medicare Advantage centerpiece would let CMS extrapolate error rates from sampled audit records across an entire plan contract, starting with payment year 2018 audits. It would also skip a fee-for-service adjuster, which insurers have long argued for.
CMS puts the recoveries at about $9 billion per payment year. It also projects nearly $90 billion in federal savings from 2027 to 2036. That is a projection, not a measured result.
On Nov. 18 Yahoo had UnitedHealth and Humana down about 6%, CVS about 3% and Cigna more than 2%. Some outlets reported UNH down as much as 9% at the lows. Closing prices may differ from these intraday moves. Mizuho's Ann Hynes named UnitedHealth and Humana as most exposed, followed by CVS, Elevance, Centene and Molina.
Why it matters
This differs from earlier 2026 episodes. In January, CMS proposed a near-flat 2027 rate (+0.09%), which sent UNH down nearly 20% in a morning. In April, CMS finalized +2.48%, about $13 billion. Those were about price. CRUSH is about enforcement: how much past overpayment plans must hand back. CMS itself cites about $21 billion a year in MA overpayments from inflated risk scores.
It also lands on top of the reported DOJ criminal and civil probe of UnitedHealth's diagnosis coding, which the company has said it is cooperating with.
Policy shock or market rout? Both. The Dow was also weighed by Nvidia's reversal after its earnings. But insurers fell hard while the Nasdaq rose about 0.4%, which points to a sector-specific cause. Sen. Elizabeth Warren's push to break up large health conglomerates is a further reported factor.
What to watch next
- Nov. 19: scheduled Federal Register publication, which sets the formal comment clock.
- Jan. 19, 2027: comment deadline per CMS's release; the published version should confirm it.
- Final rule: no date given; only the Original Medicare enrollment provision has a stated lead time.
- Insurer commentary: any quantified exposure, and whether lawyers challenge extrapolation, which was contested after CMS's 2023 audit rule.
- DOJ probe: any new disclosures on UnitedHealth's coding.
Background on how a price-weighted benchmark works is in our Dow and index guide, and the company's fundamentals are on aktienanalyse.ai.
Stocks in this analysis
AI stock analysisFree on aktienanalyse.ai: score profile, ratios versus the industry and business model. Plus, if you want it, the full analysis with fair value and bull, base and bear case. Prices and ratios as of Nov 17, 2026.
Sources (6)
This analysis is for information only and is not investment advice. Prices and figures as of publication.